Home - Australian Pharmacist

One size does not fit all

Ruth Cooper - October 9, 2000

Practice

When it comes to person-centred care, bespoke tailoring to every patient’s healthcare needs is fundamental.

Oral Antihyperglycaemics for COPD exacerbations

A/Prof Esther Lau and Prof Lisa Nissen - May 9, 2000

Clinical

Emerging evidence is pointing to the benefits of ‘novel’ antihyperglycaemics on lung function in COPD patients.

Why is my PPI not working?

AP Staff - March 12, 2000

CPD

References Gastro-oesophageal reflux in adults . In: Therapeutic Guidelines. Melbourne: Therapeutic Guidelines Limited. At: www.tg.org.au Daniels B, Schaffer A, Buckley NA, et al. The...

From the President: Caring for older Australians with compassion and expertise

Dr Fei Sim FPS BPharm (Hons) PhD FHEA GAICD FPS - May 5, 2000

Industry

At PSA we are proud to advocate for the critical role that pharmacists play in palliative care and aged care for medication supply and...

Metformin for wet (neovascular) age-related macular degeneration

Dr Esther Lau and Prof Lisa Nissen - June 12, 2000

CPD

References Khanna S, Shaw L, Hyman MJ, et al. Association of metformin use with risk of newly onset neovascular age-related macular degeneration development. Retina...

Clinical governance and the role of the pharmacist

AP Staff - October 16, 2000

CPD

References National Australia Bank Limited NAB Health Insights Special Report Part 1: The Health Consumer. November 2022. NAB Behavioural and Industrial Economics. At: https://business.nab.com.au/nab-health-insights-2022-56900/ ...

1...278279280...283 Page 279 of 283

Pharmacists are leaving the profession at an alarming rate

Inconsistencies in vaccine schedules for pharmacists are ‘needless’

It will take some time to implement change, but there are some steps governments and regulators can take now

The current funding model must be overhauled

Pharmacist prescribing programs should be nationally consistent

Improved use of technology should form the backbone of scope of practice changes

The government will respond, in time

What the health sector is saying

Pharmacists should have been involved in the vaccine rollout much sooner

Vaccination scope harmonisation needs to happen, NOW

Prescribing restrictions on ivermectin: wrong approach

Equity fail: Antivirals mainly went to the wealthy

Vaccination rates need an urgent boost

Australians won’t accept the same restrictions next time

The new CDC could re-engage Australians with vaccination, but pharmacists need to be engaged

Why are the changes occurring?

What’s occurring internationally?

Will the changes work?

Change 1: Pack sizes will shrink

Change 2: Bottles banished, blisters better

What are pharmacists’ workflow considerations?

What medicine safety messages should pharmacists be relaying?

How should patient counselling change?

Pharmacists are leaving the profession at an alarming rate

Inconsistencies in vaccine schedules for pharmacists are ‘needless’

It will take some time to implement change, but there are some steps governments and regulators can take now

The current funding model must be overhauled

Pharmacist prescribing programs should be nationally consistent

Improved use of technology should form the backbone of scope of practice changes

The government will respond, in time

What the health sector is saying

Pharmacists should have been involved in the vaccine rollout much sooner

Vaccination scope harmonisation needs to happen, NOW

Prescribing restrictions on ivermectin: wrong approach

Equity fail: Antivirals mainly went to the wealthy

Vaccination rates need an urgent boost

Australians won’t accept the same restrictions next time

The new CDC could re-engage Australians with vaccination, but pharmacists need to be engaged

Why are the changes occurring?

What’s occurring internationally?

Will the changes work?

Change 1: Pack sizes will shrink

Change 2: Bottles banished, blisters better

What are pharmacists’ workflow considerations?

What medicine safety messages should pharmacists be relaying?

How should patient counselling change?

Pharmacists are leaving the profession at an alarming rate

Inconsistencies in vaccine schedules for pharmacists are ‘needless’

It will take some time to implement change, but there are some steps governments and regulators can take now

The current funding model must be overhauled

Pharmacist prescribing programs should be nationally consistent

Improved use of technology should form the backbone of scope of practice changes

The government will respond, in time

What the health sector is saying

Pharmacists should have been involved in the vaccine rollout much sooner

Vaccination scope harmonisation needs to happen, NOW

Prescribing restrictions on ivermectin: wrong approach

Equity fail: Antivirals mainly went to the wealthy

Vaccination rates need an urgent boost

Australians won’t accept the same restrictions next time

The new CDC could re-engage Australians with vaccination, but pharmacists need to be engaged

Why are the changes occurring?

What’s occurring internationally?

Will the changes work?

Change 1: Pack sizes will shrink

Change 2: Bottles banished, blisters better

What are pharmacists’ workflow considerations?

What medicine safety messages should pharmacists be relaying?

How should patient counselling change?

Pharmacists are leaving the profession at an alarming rate

Inconsistencies in vaccine schedules for pharmacists are ‘needless’

It will take some time to implement change, but there are some steps governments and regulators can take now

The current funding model must be overhauled

Pharmacist prescribing programs should be nationally consistent

Improved use of technology should form the backbone of scope of practice changes

The government will respond, in time

What the health sector is saying

Pharmacists should have been involved in the vaccine rollout much sooner

Vaccination scope harmonisation needs to happen, NOW

Prescribing restrictions on ivermectin: wrong approach